Recent global studies highlight how more adults than ever are turning to these therapies, with over one-third of new type 2 diabetes initiations now involving GLP-1-based medications such as semaglutide or tirzepatide by late 2023, changing both the clinical and home care landscape (study data)
DEREK MUNRO: And it could easily get misconstrued that way in a clippable format
BREAKING: The FDA has approved the first oral GLP-1 pill for obesity, marking a major milestone in the weight-loss drug market and a potential inflection point for treatment access
Vineland Adaptive Behavior Scales 2nd edn Minneapolis, MN, 2005
6 In addition, pH balance, nutrient composition, gastric emptying time (gastroparesis), and gut transit time are all affected by drugs like Ozempic and can lead to an alteration of gut microbial homeostasis